Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-24 @ 4:47 PM
NCT ID:
NCT05753150
Eligibility Criteria:
Inclusion Criteria:
* Thai patient aged ≥16 years at enrolment
* Diagnosed with a mono-species, uncomplicated P. vivax malaria that is parasitologically confirmed through standardized Giemsa microscopy.
* Weighs \>35 kg
* Haemoglobin level must be \>7gm%
* Less than 24h away from emergency care
Exclusion Criteria:
* Participating in a clinical trial
* Diabetic patients who are (1) being treated with metformin (because of possible increase in the risk of lactic acidosis due to metformin when administered in combination with tafenoquine) (2) G6PD-deficient and being treated with sulfonylureas e.g. Glucotrol, Glynase, Metaglip and Micronase (because of the increased risk of haemolysis in this population).
* Pregnant/lactating women, women with suspected pregnancy.1
* Cases of severe/ complicated malaria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT05753150
Study Brief:
Protocol Section:
NCT05753150